Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Pacific Biosciences of California Inc’s stock clocked out at $1.87, down -6.03% from its previous closing price of $1.99. In other words, the price has decreased by -$6.03 from its previous closing price. On the day, 10.27 million shares were traded. PACB stock price reached its highest trading level at $2.04 during the session, while it also had its lowest trading level at $1.82.
Ratios:
To gain a deeper understanding of PACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.21 and its Current Ratio is at 7.81. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.
On April 18, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $7 to $2.50.
On December 14, 2023, Stephens started tracking the stock assigning a Overweight rating and target price of $11.Stephens initiated its Overweight rating on December 14, 2023, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’24 when Meline David W bought 40,000 shares for $4.40 per share. The transaction valued at 176,160 led to the insider holds 40,000 shares of the business.
HENRY CHRISTIAN O sold 14,177 shares of PACB for $69,056 on Mar 04 ’24. The insider now owns 2,596,670 shares after completing the transaction at $4.87 per share. On Mar 04 ’24, another insider, Van Oene Mark, who serves as the insider of the company, sold 9,186 shares for $4.87 each. As a result, the insider received 44,745 and left with 1,668,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 509281440 and an Enterprise Value of 800584000. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.54 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at 3.993 whereas that against EBITDA is -2.788.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $14.55, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is -42.85%, while the 200-Day Moving Average is calculated to be -74.72%.
Shares Statistics:
It appears that PACB traded 10.40M shares on average per day over the past three months and 11456910 shares per day over the past ten days. A total of 267.74M shares are outstanding, with a floating share count of 259.66M. Insiders hold about 4.66% of the company’s shares, while institutions hold 97.25% stake in the company. Shares short for PACB as of 1713139200 were 48520230 with a Short Ratio of 4.66, compared to 1710460800 on 45573139. Therefore, it implies a Short% of Shares Outstanding of 48520230 and a Short% of Float of 20.07.
